Gain Therapeutics Inc. (GANX)
NASDAQ: GANX
· Real-Time Price · USD
1.73
0.19 (12.34%)
At close: Aug 15, 2025, 3:59 PM
1.76
1.73%
After-hours: Aug 15, 2025, 07:49 PM EDT
Gain Therapeutics Fail-to-Deliver
Total FTD Shares
929
Below Average
FTD / Avg. Volume
0.34%
Low Impact
1-Year Change
-99.9%
Negative Trend
FTD Chart
As of Jun 26, 2025,
Gain Therapeutics Inc. has
929
shares failed to deliver, representing 0.34%
of the average daily volume of
269,348
shares. Over the past year, the monthly average FTD is
81,701
shares, with the current level 99% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jun 26, 2025 | 1.99 | 929 | -27.31% |
Apr 25, 2025 | 1.9 | 1.28K | -14.80% |
Jan 23, 2025 | 2.23 | 1.5K | +50.00% |
Dec 19, 2024 | 1.57 | 1K | +16.82% |
Nov 26, 2024 | 1.73 | 856 | -95.35% |
Oct 31, 2024 | 2.5 | 18.41K | +2201.50% |
Sep 30, 2024 | 1.78 | 800 | -99.22% |
Aug 30, 2024 | 1.09 | 102.68K | +8261.81% |
Jul 31, 2024 | 1.08 | 1.23K | -99.84% |
Jun 28, 2024 | 1.28 | 785.62K | +257481.31% |
May 06, 2024 | 2.85 | 305 | +52.50% |
Apr 30, 2024 | 2.93 | 200 | +589.66% |
Mar 27, 2024 | 3.73 | 29 | -96.62% |
Feb 23, 2024 | 4.55 | 857 | +12142.86% |
Jan 18, 2024 | 3.36 | 7 | -99.56% |
Dec 29, 2023 | 3.27 | 1.58K | +157600.00% |
Nov 10, 2023 | 2.74 | 1 | -99.91% |
Oct 05, 2023 | 3.22 | 1.08K | +65.34% |
Sep 26, 2023 | 3.2 | 655 | -96.24% |
Jul 17, 2023 | 4.49 | 17.41K | +16320.75% |
Jun 30, 2023 | 4.48 | 106 | -1.85% |
May 30, 2023 | 4.59 | 108 | +285.71% |
Apr 21, 2023 | 5.43 | 28 | -99.62% |
Mar 31, 2023 | 4.82 | 7.3K | +173.92% |
Feb 28, 2023 | 4.16 | 2.67K | -54.91% |
Jan 31, 2023 | 3.95 | 5.91K | n/a |